Skip to content

Save the Ovaries - Surgical Management of Simple Ovarian Cysts in Children and Adolescents

Save the Ovaries - Surgical Management of Simple Ovarian Cysts in Children and Adolescents

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06852313
Enrollment
80
Registered
2025-02-28
Start date
2026-02-05
Completion date
2028-12-01
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cyst Benign

Keywords

Ovarian cyst, Laparoscopy, Child

Brief summary

The purpose of this study is to evaluate which operative technique should be used for managing simple ovarian cysts in girls and adolescents. The two techniques that are being compared are laparoscopic cyst enucleation and laparoscopic cyst deroofing. The investigators will assess the effect of both techniques on the ovarian reserve and the risk of cyst recurrence.

Interventions

PROCEDURELaparoscopic ovarian cyst surgery

Laparoscopic ovarian cyst surgery is any surgery with the goal of removal or drainage of an ovarian cyst. The exact surgical technique will be predefined by randomization.

Sponsors

University Children's Hospital, Zurich
Lead SponsorOTHER
University Children's Hospital Basel
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
1 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Symptomatic simple cysts ≥ 4 cm with indication for surgical intervention * Asymptomatic cysts ≥ 4 cm, with surgical indication due to persistence or increase in size * Asymptomatic cysts ≥ 4 cm with other pathology as surgical indication, if known preoperatively * Age 12 months - 18 years * Parents/legal custodian and patient give consent, for patients unable to consent due to their health condition or developmental status they show no signs of unwillingness to participate * Symptomatic simple cysts ≥ 4 cm with indication for surgical intervention on both ovaries (each ovary will count as one)

Exclusion criteria

* Neonatal ovarian cysts (age \<12 months) * Age \>18 years * Complex cysts (with solid components, e.g., Teratoma, risk or suspicion of malignancy) * Paratubar/paraovarian cysts * Medical reason that precludes cyst enucleation (e.g. severe coagulopathy) * Neither signed informed consent form or inadequate german, french or english language skills to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Postoperative change of AMH level8 weeksChange in AMH level postoperatively compared to preoperative AMH levels (measured in pmol/L).

Secondary

MeasureTime frameDescription
Postoperative recurrence rate14 weeksPostoperative recurrence is defined as an ipsilateral asymptomatic cyst ≥ 4cm or a cyst of any size that requires a medical or surgical intervention due to symptoms at follow-up 6-8 weeks postoperatively. If the asymptomatic cyst is \< 4cm, a second follow-up will be performed at 10-14 weeks postoperatively. Recurrence is then defined as ipsilateral asymptomatic cyst ≥ 4cm or a cyst of any size that requires a medical or surgical intervention due to symptoms. The outcome will be measured as "recurrence/no recurrence"

Countries

Switzerland

Contacts

CONTACTUchenna Kennedy, MD
uchenna.kennedy@kispi.uzh.ch0041 2494949
CONTACTUeli Möhrlen, Prof. Dr. med.
ueli.möhrlen@kispi.uzh.ch00412494949

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026